Peter Lawson analyst BARCLAYS

Currently out of the existing stock ratings of Peter Lawson, 9 are a SELL (5.7%), 133 are a BUY (84.18%), 16 are a HOLD (10.13%).

Peter Lawson

Work Performance Price Targets & Ratings Chart

Analyst Peter Lawson works at BARCLAYS with a stock forecast success ratio of 62.05% fulfilled within 226.79 days on average.

Peter Lawson’s has documented 335 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARVN, Arvinas at 29-Feb-2024.

Wall Street Analyst Peter Lawson

Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for CLVS (CLOVIS ONCOLOGY) at 9/8/2015. The price target of $103 was fulfilled within 2 days with a profit of $18.62 (22.07%) receiving and performance score of 110.33.

Average potential price target upside

AGIO Agios Pharm BPMC Blueprint Medicines Corp CLVS Clovis Oncology CTMX CytomX Therapeutics DCPH Deciphera Pharmaceuticals LLC EPZM Epizyme FATE Fate Therapeutics IOVA Iovance Biotherapeutics KPTI Karyopharm Therapeutics KURA Kura Oncology MGNX MacroGenics PRLD Prelude Therapeutics  RCUS Arcus Biosciences SNDX Syndax Pharmaceuticals SWTX SpringWorks Therapeutics XNCR Xencor YMAB Y mAbs Therapeutics ILMN Illumina ADAP Adaptimmune Therapeutics Plc FLDM Fluidigm LUMO Lumos Pharma MRTX Mirati Ther NLNK NewLink Genetics NEXI Neximmune XON Precigen EXAS EXACT Sciences IMGN ImmunoGen INCY yte ARVN Arvinas AFMD Affimed NV CDNA Caredx CRSP Crispr Therapeutics AG EXEL Exelixis IMMU Immunomedics REPL Replimune Group RLAY Relay Therapeutics  BMEA Biomea Fusion EXAI Exscientia Ltd ADR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

30

$2.3 (8.30%)

32

1 months 29 days ago

3/3 (100%)

$-2.99 (-9.06%)

224

Hold

28

$0.3 (1.08%)

32

5 months 18 days ago

6/6 (100%)

$5.51 (24.50%)

192

Buy

42

$14.3 (51.62%)

67

9 months 25 days ago

5/12 (41.67%)

$13.87 (49.31%)

213

Buy

38

$10.3 (37.18%)

40

9 months 25 days ago

0/4 (0%)

$9.87 (35.09%)

Buy

37

$9.3 (33.57%)

33

1 years 8 months 16 days ago

6/11 (54.55%)

$7.26 (24.41%)

69

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Peter Lawson is most bullish on?

Potential upside of $22.35 has been obtained for ARVN (ARVINAS)

Which stock is Peter Lawson is most reserved on?

Potential downside of -$21.54 has been obtained for BPMC (BLUEPRINT MEDICINES CORP)

What Year was the first public recommendation made by Peter Lawson?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?